NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/13/2022
Back to search
Official data from USPTO
VIENNA LAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
09/13/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/18/2021
Registration date
09/13/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2022
Last transaction
09/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/01/2003
First use in commerce
02/01/2003
Drawing code
4
Owner type
99
Owner location
Vienna, AT
Examiner
MCDORMAN, ROGER
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ViennaLab Diagnostics GmbH
Representatives
MICHAEL FEDRICK LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations and reagents for medical purposes; medical diagnostic reagents; reagents for medical diagnostic purposes; medical diagnostic reagents and assays for determining genetic mutations or polymorphismsin particular mutations or polymorphisms relating to cardiovascular diseasecongenital adrenal hyperplasiafamilial mediterranean fevercystic fibrosisthalassemiaand Gaucher disease; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutations or polymorphisms in genes for medical purposes; preparations for detecting mutations or polymorphisms in genes related to cancer or related to a response to therapeutic interventions; medical diagnostic test strips for use in determining genetic mutations or polymorphisms
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/19/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/19/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/19/2022
DOCK
ASSIGNED TO EXAMINER
05/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2021
NWAP
NEW APPLICATION ENTERED
08/21/2021
Continuous trademark protection
Get notified about every new filing that threatens VIENNA LAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.